MoneyWorks4Me

Sakar Healthcare - Quaterly Results

25 Jul 2025 Evaluate
The Sales for the quarter ended June 2025 of Rs. 527.36 millions rose by 28.16% from Rs. 411.48 millions.Net profit for the quarter ended June 2025 increased significantly by 93.66% to Rs. 46.71 millions from Rs. 24.12 millions.Operating Profit saw a handsome growth to 131.00 millions from 111.59 millions in the quarter ended June 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 527.36 411.48 28.16 527.36 411.48 28.16 1775.85 1533.52 15.80
Other Income 3.94 4.60 -14.35 3.94 4.60 -14.35 13.13 31.77 -58.67
PBIDT 131.00 111.59 17.39 131.00 111.59 17.39 509.96 415.41 22.76
Interest 21.43 13.98 53.29 21.43 13.98 53.29 85.35 75.90 12.45
PBDT 109.57 97.61 12.25 109.57 97.61 12.25 424.10 339.51 24.92
Depreciation 55.72 50.58 10.16 55.72 50.58 10.16 208.82 180.50 15.69
PBT 53.85 47.03 14.50 53.85 47.03 14.50 215.28 159.01 35.39
TAX 7.14 22.91 -68.83 7.14 22.91 -68.83 40.25 42.29 -4.82
Deferred Tax 7.14 22.91 -68.83 7.14 22.91 -68.83 40.25 42.29 -4.82
PAT 46.71 24.12 93.66 46.71 24.12 93.66 175.03 116.72 49.96
Equity 222.50 217.50 2.30 222.50 217.50 2.30 219.50 217.50 0.92
PBIDTM(%) 24.84 27.12 -8.40 24.84 27.12 -8.40 28.72 27.09 6.01
Peers
Company Name CMP
Sun Pharma. Inds. 1864.00
Dr. Reddys Labs. 1140.80
Cipla 1380.00
Lupin 2075.00
Zydus Lifesciences 1118.00
View more..